State Of Wyoming Verastem, Inc. Transaction History

State Of Wyoming

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.06 - $2.1 $1,223 - $2,423	-1,154 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$2.05 - $3.2 $131 - $204	-64 Reduced 5.25%	1,154 $2,000
Q3 2021 Feb 11, 2022	SELL	$2.54 - $4.07 $533 - $854	-210 Reduced 14.71%	1,218 $4,000
Q2 2021 Feb 11, 2022	BUY	$2.57 - $4.85 $3,669 - $6,925	1,428 New	1,428 $6,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.25B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.